{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:51:36Z","timestamp":1762865496949,"version":"3.41.2"},"reference-count":19,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p><jats:bold>Objective\u2002<\/jats:bold> To compare the efficacy of 100 mg and 200 mg of mifepristone and 24\u2010 and 48\u2010hour intervals to administration of 800\u03bcg vaginal misoprostol for termination of early pregnancy.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Placebo\u2010controlled, randomized, equivalence trial, stratified by centre.<\/jats:p><jats:p><jats:bold>Setting\u2002<\/jats:bold> 13 departments of obstetrics and gynecology in nine countries.<\/jats:p><jats:p><jats:bold>Population\u2002<\/jats:bold> 2181 women with 63 days or less gestation requesting medical abortion.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Two\u2010sided 95% CI for the risk differences of failure to complete abortion were calculated and compared with 5% equivalence margin between two doses of mifepristone and two intervals to misoprostol administration. Proportions of women with adverse effects were compared between the regimens using standard testes for proportions.<\/jats:p><jats:p><jats:bold>Outcome measures\u2002<\/jats:bold> Rates of complete abortion without surgical intervention and adverse effects associated with the regimens.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Efficacy outcome was analysed for 2126 women (97.5%) excluding 55 lost to follow up. Both mifepristone doses were found to be similar in efficacy. The rate of complete abortion was 92.0% for women assigned 100 mg of mifepristone and 93.2% for women assigned 200 mg of mifepristone (difference 1.2%, 95% CI: \u20131.0 to 3.5). Equivalence was also evident for the two intervals of administration: the rate of complete abortion was 93.5% for 24\u2010hour interval and 91.7% for the 48\u2010hour interval (difference \u22121.8%, 95% CI: \u20134.0 to 0.5). Interaction between doses and interval to misoprostol administration was not significant (P = 0.92). Adverse effects related to treatments did not differ between the groups.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Both the 100 and 200 mg doses of mifepristone and the 24\u2010 and 48\u2010hour intervals have a similar efficacy to achieve complete abortion in early pregnancy when mifepristone is followed by 800 micrograms of vaginally administered misoprostol.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2008.02034.x","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T04:33:01Z","timestamp":1232512381000},"page":"381-389","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial*"],"prefix":"10.1111","volume":"116","author":[{"given":"H","family":"von Hertzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Piaggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Wojdyla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Marions","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NT","family":"My Huong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OS","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AH","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SC","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Kalmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Erdenetungalag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Horga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Pretnar\u2010Darovec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Kapamadzija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ND","family":"Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NV","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HTD","family":"Tuyet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Peregoudov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"WHO Research Group on Post\u2010ovulatory Methods of Fertility Regulation","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6903.532"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13273.x"},{"key":"e_1_2_11_4_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1034\/j.1600-0412.2001.d01-462.x","article-title":"Medical abortion at 57 to 63 days\u2019 gestation with a lower dose of mifepristone and gemeprost: a randomized controlled trial","volume":"80","author":"World Health Organization Task Force on Post\u2010ovulatory Methods for Fertility Regulation","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"e_1_2_11_5_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(16)54412-4","article-title":"Pregnancy termination with mifepristone and gemeprost: a multicentre comparison between repeated doses and a single dose of mifepristone","volume":"56","author":"World Health Organization Task Force on Post\u2010ovulatory Methods for Fertility Regulation","year":"1991","journal-title":"Fertil Steril"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2001.00171.x"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853899309147861"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(85)90115-5"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.106767"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349209021052"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.15.1948"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000258298.35143.d2"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01179.x"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.10.1152"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200109000-00013"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh005"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60522-6"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60914-3"},{"key":"e_1_2_11_19_2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1471-0528.2003.02430.x","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion: I Efficacy","volume":"110","author":"von Hertzen H","year":"2003","journal-title":"BJOG"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(02)00492-4"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2008.02034.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2008.02034.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T08:56:58Z","timestamp":1753088218000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2008.02034.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1471-0528.2008.02034.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2008.02034.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"type":"print","value":"1470-0328"},{"type":"electronic","value":"1471-0528"}],"subject":[],"published":{"date-parts":[[2009,1,21]]},"assertion":[{"value":"2009-01-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}